Method and Apparatus for the Capture of Intra-cellular Activity Read more about Method and Apparatus for the Capture of Intra-cellular Activity US Patent 11,627,907Filed on 2019-06-24
DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AND USES THEREOF Read more about DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AND USES THEREOF Patent Cooperation TreatyPCT/US2019/050165Filed on 2019-09-09
Auto Rim-Shaped Gradient Coil Read more about Auto Rim-Shaped Gradient Coil US Patent 10,739,427Filed on 2019-01-04
POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF Read more about POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF US Patent 10,913,711Filed on 2019-02-22
BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME Read more about BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME Patent Cooperation TreatyPCT/US2019/022701Filed on 2019-03-18
DREADD ACTUATORS Read more about DREADD ACTUATORS Patent Cooperation TreatyPCT/US2019/016892Filed on 2019-02-06
ATYPICAL INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF Read more about ATYPICAL INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF Patent Cooperation TreatyPCT/US2018/060260Filed on 2018-11-12
Novel Dopamine D3 Receptor Selective Anatgonists/Partial Agonists with High Affinity and Metabolic Stability for Treatment of Neuropsychiatric Disorders Read more about Novel Dopamine D3 Receptor Selective Anatgonists/Partial Agonists with High Affinity and Metabolic Stability for Treatment of Neuropsychiatric Disorders Australia2017233716Filed on 2017-03-08
Novel Dopamine D3 Receptor Selective Antagonists/partial Agonists With High Affinity And Metabolic Stability For Treatment Of Neuropsychiatric Disorders Read more about Novel Dopamine D3 Receptor Selective Antagonists/partial Agonists With High Affinity And Metabolic Stability For Treatment Of Neuropsychiatric Disorders US Patent 11,299,476Filed on 2018-09-11
Novel Dopamine D3 Receptor Selective Anatgonists/Partial Agonists with High Affinity and Metabolic Stability for Treatment of Neuropsychiatric Disorders Read more about Novel Dopamine D3 Receptor Selective Anatgonists/Partial Agonists with High Affinity and Metabolic Stability for Treatment of Neuropsychiatric Disorders European Patent17711971.6Filed on 2018-09-11